Quantinuum (NASDAQ:QNT) Stock Keeps “Buy” Rating at Rosenblatt Securities

Quantinuum (NASDAQ:QNT)‘s stock had its “buy” rating reaffirmed by Rosenblatt Securities in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $155.00 price objective on the stock. Rosenblatt Securities‘s price target would indicate a potential upside of 336.62% from the company’s previous close.

QNT has been the topic of a number of other research reports. UBS Group began coverage on Quantinuum in a research report on Monday, June 29th. They set a “buy” rating and a $93.00 price objective on the stock. Evercore assumed coverage on Quantinuum in a research report on Monday, June 29th. They issued an “outperform” rating and a $98.00 target price for the company. Sanford C. Bernstein reissued a “hold” rating on shares of Quantinuum in a research note on Wednesday, August 12th. Jefferies Financial Group set a $85.00 price target on Quantinuum in a research note on Wednesday, August 12th. Finally, Craig Hallum assumed coverage on Quantinuum in a report on Monday, June 29th. They set a “buy” rating and a $100.00 price target on the stock. Thirteen equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.23.

Quantinuum Stock Performance

Quantinuum stock traded down $3.15 during mid-day trading on Thursday, reaching $35.50. The company had a trading volume of 778,297 shares, compared to its average volume of 2,308,754. The company has a fifty day moving average of $48.70. The firm has a market cap of $9.35 billion and a P/E ratio of -126.79. Quantinuum has a fifty-two week low of $33.02 and a fifty-two week high of $86.79.

Quantinuum (NASDAQ:QNT) last announced its quarterly earnings results on Tuesday, August 11th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.02). The firm had revenue of $8.00 million for the quarter. Sell-side analysts predict that Quantinuum will post -4.76 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Quantinuum

Several large investors have recently modified their holdings of the business. SBI Securities Co. Ltd. raised its position in Quantinuum by 52.8% during the 3rd quarter. SBI Securities Co. Ltd. now owns 6,778 shares of the company’s stock worth $326,000 after purchasing an additional 2,343 shares during the last quarter. IFP Advisors Inc raised its position in Quantinuum by 1,150.0% during the 3rd quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock worth $60,000 after purchasing an additional 1,150 shares during the last quarter. Counterpoint Mutual Funds LLC bought a new position in Quantinuum during the 3rd quarter worth $408,000. Vontobel Holding Ltd. bought a new position in Quantinuum during the 3rd quarter worth $743,000. Finally, Parisi Gray Wealth Management raised its position in Quantinuum by 508.7% during the 3rd quarter. Parisi Gray Wealth Management now owns 18,717 shares of the company’s stock worth $900,000 after purchasing an additional 15,642 shares during the last quarter.

About Quantinuum

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.